IAA
ATOS icon

Independent Advisor Alliance’s Atossa Therapeutics ATOS Stock Holding History

Independent Advisor Alliance’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-667
Closed -$21K – 620
2021
Q1 		$21K Buy
+667
New +$24.4K ﹤0.01% 586

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Independent Advisor Alliance's ATOS Position: Q2 2021 in Review

Independent Advisor Alliance sold out of Atossa Therapeutics (ATOS) in Q2 2021, closing a stake of 667 shares — an estimated $21K sold.

Independent Advisor Alliance first reported a position in ATOS in Q1 2021 and held it in 1 quarter. The position peaked at $21K in Q1 2021. 86 funds tracked by Wall St. Rank hold ATOS as of Q2 2021.

  • Independent Advisor Alliance reported no remaining Atossa Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Independent Advisor Alliance sold 667 Atossa Therapeutics shares in Q2 2021, an estimated $21K.
  • Independent Advisor Alliance first reported a position in Atossa Therapeutics in Q1 2021 and held it in 1 quarter.
  • Independent Advisor Alliance's Atossa Therapeutics position peaked at $21K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2021.

Based on Independent Advisor Alliance's 13F filing for Q2 2021, filed 12 Aug 2021.